INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Quarterly Results

Change Company Name

Glenmark Pharmaceuticals Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 532296	ISIN Demat INE935A01035	Book Value 868.32	NSE Symbol GLENMARK	Dividend Yield (%) 0.15	Market Cap (₹ Cr.) 47,119.07	P/E 27.01	EPS 61.81	Face Value 1

Particulars (₹ Cr)	Mar 2025	Dec 2024	Sep 2024	Jun 2024

Gross Sales/Income from operations	1909.94	2208.84	2594.89	2296.88
Less: Excise duty	0.00	0.00	0.00	0.00
Net Sales/Income from operations	1,909.94	2,208.84	2,594.89	2,296.88
Other Operating Income	99.56	42.44	41.21	32.66
Total Income from operations (net)	2,009.49	2,251.28	2,636.10	2,329.54
Total Expenses	1,724.50	1,812.52	1,912.32	1,751.52
Cost of Sales	786.12	784.89	834.10	794.02
Employee Cost	382.70	427.98	408.42	384.40
Depreciation, amortization and depletion expense	55.53	55.16	54.85	53.09
Provisions & Write Offs	0.00	0.00	0.00	0.00
Administrative and Selling Expenses	0.00	0.00	0.00	0.00
Other Expenses	500.15	544.48	614.96	520.01
Pre Operation Expenses Capitalised	0.00	0.00	0.00	0.00
Profit from operations before other income, finance costs and exceptional items	285.00	438.76	723.78	578.02
Other Income	88.45	129.19	83.08	55.65
Profit from ordinary activities before finance costs and exceptional items	373.45	567.95	806.85	633.66
Finance Costs	13.13	8.46	11.80	15.35
Profit from ordinary activities after finance costs but before exceptional items	360.32	559.49	795.06	618.31
Exceptional Items	-179.17	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00
Profit from ordinary activities before tax	181.16	559.49	795.06	618.31
Total Tax	33.40	145.69	200.00	164.58
Net profit from Ordinary Activities After Tax	147.76	413.80	595.06	453.73
Profit / (Loss) from Discontinued Operations	0.00	0.00	0.00	0.00
Net profit from Ordinary Activities/Discontinued Operations After Tax	147.76	413.80	595.06	453.73
Extraordinary items	0.00	0.00	0.00	0.00
Other Adjustments After Tax	0.00	0.00	0.00	0.00
Net Profit after tax for the Period	147.76	413.80	595.06	453.73
Other Comprehensive Income	-3.00	-0.53	-2.12	-0.82
Total Comprehensive Income	144.76	413.27	592.94	452.92
Equity	28.22	28.22	28.22	28.22
Reserve & Surplus	0.00	0.00	0.00	0.00
Face Value	1.00	1.00	1.00	1.00
EPS:
EPS before Exceptional/Extraordinary items-Basic	11.59	14.66	21.09	16.08
EPS before Exceptional/Extraordinary items-Diluted	11.59	14.66	21.09	16.08
EPS after Exceptional/Extraordinary items-Basic	5.24	14.66	21.09	16.08
EPS after Exceptional/Extraordinary items-Diluted	5.24	14.66	21.09	16.08
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00
Dividend Per Share(Rs.)	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00
No. of Employees	0.00	0.00	0.00	0.00
Debt Equity Ratio	0.00	0.00	0.00	0.00
Debt Service Coverage Ratio	0.00	0.00	0.00	0.00
Interest Service Coverage Ratio	0.00	0.00	0.00	0.00
Debenture Redemption Reserve (Rs cr)	0.00	0.00	0.00	0.00
Paid up Debt Capital (Rs cr)	0.00	0.00	0.00	0.00